SynergEyes, Inc. (Carlsbad, Calif.) recently received a CONNECT Most Innovative New Product (MIP) Award for 2009 for its patent-pending ClearKone hybrid contact lenses designed for people with keratoconus.
CONNECT is a regional nonprofit organization dedicated to creating and sustaining the growth of innovative technology and life sciences businesses in the San Diego area.
The MIP Award finalists were selected from approximately 100 entries representing a broad range of companies within eight categories. The SynergEyes ClearKone hybrid contacts won the MIP Award in the Life Science – Medical Products category.
ClearKone hybrid contact lenses are designed specifically for people with moderate to advanced keratoconus who characteristically have poor vision with eyeglasses. The patent-pending hybrid lens design is optimized to vault the irregularities of the keratoconic cornea, thereby restoring visual acuity to a vast majority of patients without compromising comfort or eye health, according to the company.
“It is a great honor to receive an award recognizing SynergEyes as a technology leader among the medical device companies in San Diego,” said Kellie Kaseburg, Vice President of Global Marketing, in a press release issued by SynergEyes, Inc.
Since the market release of ClearKone hybrid contact lenses in May 2009, approximately 2,500 keratoconus patients have been prescribed the lenses, the company says.
To learn more about SynergEyes hybrid contacts and to find an eye doctor that prescribes ClearKone lenses for keratoconus, visit TreatKeratoconus.com.
Subscribe to our RSS feedTags: Hybrid Contacts, Keratoconus
